Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


STEMdiff™ - Products for Differentiating Human Pluripotent Stem Cells

Product Image
Product Description

STEMdiff™ is a line of products from STEMCELL Technologies Inc. specifically optimized for the differentiation of human pluripotent stem cells (hPSCs).  

STEMdiff™ APEL™ Medium (Catalog #05210)
STEMdiff™ APEL™ Medium is a defined, serum-free and animal component-free medium
specifically developed to support hPSC differentiation along ectoderm, mesoderm and endoderm lineages. Developed by STEMCELLTechnologies and based on a published formulation (Ng ES et al. Nat Protoc. 3:768-776, 2008).  STEMdiff™ APEL™ Medium is a versatile, growth factor-free, basal medium that is to be supplemented with specific lineage-inducing factors. Although optimized to be used following maintenance in either
mTeSR™1 or TeSR™2 media and using the EB-based AggreWell™ system, this medium
can also be used to differentiate cells in adherent cell-based systems.  (For more information on AggreWell™ for uniformly-sized EB formation, please visit www.stemcell.com/aggrewell)

Advantages
•    Defined
•    Animal component-free
•    Versatile, growth factor-free formulation to allow for differentiation to multiple lineages

STEMdiff™ Neural Induction Medium (Catalog #05831)
STEMdiff™ Neural Induction Medium is a defined, serum-free medium that is part of a complete system for the differentiation of hPSCs to neural progenitor cells in as little as 12 days. This medium rapidly and efficiently forms neural rosette clusters when used in conjunction with AggreWell™ 800 plates, which ensure uniformly-sized neural aggregate formation.

MDC-Product-Feature_Neural-Rosettes copy.gif
Neural rosette clusters formed using STEMdiff™ Neural Induction Medium can then
be selected and isolated for further experiments using enzyme-free STEMdiff™
Neural Rosette Selection Reagent (Catalog #05832).  Using this novel reagent, neural rosettes virtually “lift off” the plate and do not require any manual isolation. Together this is a complete, convenient and highly efficient system to obtain up to 100% single neural progenitor cells within 12 days.

Advantages
•    Defined
•    Serum-free
•    Rapid and efficient neural induction
                * Neural rosettes within 6 days
                * Single cell NPC populations within 12 days

STEMdiff™ Hematopoietic Differentiation Kit (Catalog #05310) – Coming Soon!
STEMdiff™ Hematopoietic Differentiation Kit is optimized for the differentiation of hPSCs to the hematopoietic lineage and will be available soon.

Advantages
•    Optimized for hPSC differentiation to the hematopoietic lineage
•    Easy-to-use 13-day protocol
•    From hPSCs, generates CD34+ and CD34+CD45+ hematopoietic cells and an average of 150 CFCs per 100,000 cells

For more information about the STEMdiff™ product line, please visit www.stemcell.com/STEMdiff

Product STEMdiff™ - Products for Differentiating Human Pluripotent Stem Cells
Company StemCell Technologies
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

StemCell Technologies
40 Rues des Berges Miniparc Polytec Bâtiment Sirocco, 38000 Grenoble France

Tel: +33.(0)4.76.04.75.30
Fax: +33.(0).4.76.18.99.63
Email: Product.management@stemcell.com



Scientific News
Bile Acid Supports Production of Blood Stem Cells
A research group at Lund University has been able to show that bile acid is transferred from the mother to the foetus via the placenta to enable the foetus to produce blood stem cells.
New Biomarker to Assess Stem Cells Developed
A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Edited Stem Cells Offer Hope of Precision Therapy for Blindness
Findings raise the possibility of treating blinding eye diseases using a patient's own corrected cells as replacement tissue.
Hacking the Programs of Cancer Stem Cells
All tumor cells are the offspring of a single, aberrant cell, but they are not all alike.
Newfound Strength in Regenerative Medicine
A promising new approach uses direct mechanical stimulation to repair severely damaged skeletal muscles.
Mapping out Cell Conversion
Researchers develop algorithm that takes the field of cell reprogramming forward.
Donor's Genotype Controls the Differentiation of IPS Cells
Pluripotent stem cells derived from different cell types are equally susceptible to reprogramming, indicates a recent study by the University of Helsinki and the National Institute for Health and Welfare, Finland. However, the genotype of the donor strongly influences the differentiation of the stem cell.
Signals That Make Early Stem Cells Identified
Researchers at The Rockefeller University have identified a new mechanism by which cells are instructed during development to become stem cells
Healing Scarred Hearts
Findings suggest stem cells may one day be used to regenerate damaged tissue after heart attack.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!